American Journal of Neuroradiology 24:2085-2088, November-December 2003
© 2003 American Society of Neuroradiology
Case Report
PEDIATRICS
Severe Tacrolimus Leukoencephalopathy after Liver Transplantation
a Department of Neurology, University Medical Center Nijmegen, Nijmegen, the Netherlands
b Department of Pathology, University Medical Center Nijmegen, Nijmegen, the Netherlands
c Department of Pediatric Neurology, University Medical Center Nijmegen, Nijmegen, the Netherlands
Address correspondence to Dr. Aad Verrips, Department of Pediatric Neurology, University Medical Center Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, the Netherlands
Summary: Tacrolimus is an immunosuppressive agent that can show a wide variety of neurologic side effects, including leukoencephalopathy. Although the prognosis is goodafter cessation or dose reduction, complete recovery usually occursthe differentiation with treatable diseases such as progressive multifocal encephalopathy can be difficult, making a stereotactic biopsy of the white matter lesion sometimes necessary. We describe the case of a 12-year-old girl with a severe, reversible tacrolimus-related leukoencephalopathy and only mild histopathologic abnormalities.
This article has been cited by other articles:
![]() |
B. D. Korman, K. L. Tyler, and N. J. Korman Progressive Multifocal Leukoencephalopathy, Efalizumab, and Immunosuppression: A Cautionary Tale for Dermatologists Arch Dermatol, August 1, 2009; 145(8): 937 - 942. [Full Text] [PDF] |
||||
![]() |
C. Horbinski, W.S. Bartynski, E. Carson-Walter, R.L. Hamilton, H.P. Tan, and S. Cheng Reversible Encephalopathy after Cardiac Transplantation: Histologic Evidence of Endothelial Activation, T-Cell Specific Trafficking, and Vascular Endothelial Growth Factor Expression AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 588 - 590. [Abstract] [Full Text] [PDF] |
||||

